en · de · es
cardarine-notes.peptides1004.com › Guide › Preclinical Findings And Safety Signals — What the Evidence Shows

Preclinical Findings And Safety Signals — What the Evidence Shows

By Editorial Desk · published 2025-10-20 · last reviewed 2025-12-10 · Guide

The short version of WADA Prohibited List fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-12-10 and is reviewed periodically as new material appears.

Preclinical Findings and Safety Signals

Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.

Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.

Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.

Identity and Regulatory Status

Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.

Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.

Cardarine at a glance

PropertyValueNotes
Primary targetPPARδ (NR1C2)Nuclear receptor involved in lipid metabolism
Preclinical effectIncreased fatty acid oxidationObserved in rodent studies
Key safety signalTumors in rodents after long-term exposureContributed to halted clinical development
Human trial statusNo approved product; development stoppedLimited short-term metabolic data
Sport regulatory statusProhibited at all timesWADA hormone and metabolic modulators class

Regulatory Status and Detection Context

Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.

A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Related pages on this site

Detection, Regulation, and Quality Context

Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.

Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.

Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.

Detection, Stability, and Quality

Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.

Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.

Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.

Reference notes

==== Affinity proteomics ==== Affinity proteomics uses antibodies or other affinity reagents (such as oligonucleotide-based aptamers) as protein-specific detection probes. Currently this method can interrogate several thousand proteins, typically from biofluids such as plasma, serum or cerebrospinal fluid (CSF). A key differentiator for this technology is the ability to analyze hundreds or thousands of samples in a reasonable timeframe (a matter of days or weeks); mass spectrometry-based methods are not scalable to this level of sample throughput for proteomics analyses.

== Measured variables and units == In principle, reducing the exposure of the human organism to ionizing radiation to zero is not possible and perhaps not even sensible. The human organism has been accustomed to natural radioactivity for thousands of years and ultimately this also triggers mutations (changes in genetic material), which are the cause of the development of life on earth. The mutation-inducing effect of high-energy radiation was first demonstrated in 1927 by Hermann Joseph Muller (1890-1967). Three years after its establishment in 1958, the United Nations Scientific Committee on the Effects of Atomic Radiation adopted the Linear No-Threshold (LNT) model - a linear dose-effect relationship without a threshold - largely at the instigation of the Soviet Union. The dose-response relationship measured at high doses was extrapolated linearly to low doses. There would be no threshold, since even the smallest amounts of ionizing radiation would trigger some biological effect. The LNT model ignores not only possible radiation hormesis, but also the known ability of cells to repair genetic damage and the ability of the organism to remove damaged cells. Between 1963 and 1969, John W. Gofman (1918-2007) and Arthur R. Tamplin of the University of California, Berkeley, conducted research for the United States Atomic Energy Commission (USAEC, 1946-1974) investigating the relationship between radiation doses and cancer incidence. Their findings sparked a fierce controversy in the United States beginning in 1969. Starting in 1970, Ernest J.

is rather small, in the convenience of comparison between difference samples, the notation is define as a ratio minus 1 and expressed in permil (‰). The Δ notation is inherited from traditional δ notation. But the reference is not a physical reference material. Instead, the reference frame is defined as the stochastic distribution of isotopologues in the sample. It means the values of Δ are to denote the excess or deficit of the isotopologue relative to the amount expected if a material conforms to the stochastic distribution. The calculation of stochastic distribution of methane isotopologues:

Sources: en.wikipedia.org

Notes from published material

=== Encounters with humans === Attacks on humans are rare, but Komodo dragons have been responsible for several human fatalities, both in the wild and in captivity. According to data from Komodo National Park spanning a 38-year period between 1974 and 2012, there were 24 reported attacks on humans, five of them fatal. Most of the victims were local villagers living around the national park. Komodo dragons generally avoid encounters with humans. Juveniles are very shy and will flee quickly into a hideout if a human comes closer than about 100 metres (330 ft). Older animals will also retreat from humans from a shorter distance away. If cornered, they may react aggressively by gaping their mouth, hissing, and swinging their tail. If they are disturbed further, they may attack and bite. Although there are anecdotes of unprovoked Komodo dragons attacking or preying on humans, most of these reports are either not reputable or have subsequently been interpreted as defensive bites. Only very few cases are truly the result of unprovoked attacks by atypical individuals who lost their fear of humans.

== Properties == The alcohol dehydrogenases comprise a group of several isozymes that catalyse the oxidation of primary and secondary alcohols to aldehydes and ketones, respectively, and also can catalyse the reverse reaction. In mammals this is a redox (reduction/oxidation) reaction involving the coenzyme nicotinamide adenine dinucleotide (NAD+).

Looking at Poland's History Through the Prism of Art History of Poland, in paintings History of Poland on Historycy.org forum History of Poland: Primary Documents Commonwealth of Diverse Cultures: Poland's Heritage Archived 2011-06-24 at the Wayback Machine "Poland, Christianity in" The New Schaff-Herzog Encyclopedia of Religious Knowledge (1910) vol 9 pp. 104–8 Williams, Henry Smith (Ed.) 1905, The Historians' History of the World in twenty-five volumes, volume 17: Switzerland (concluded), Russia and Poland, New York: The Outlook Company.

=== Research and regulation === Rhodiola has been used as a dietary supplement. According to Memorial Sloan Kettering Cancer Center, Rhodiola rosea is used in Asia and Eastern Europe in the forms of capsules, liquid extracts and tablets as a traditional medicine. Through 2019, human studies evaluating R. rosea did not have sufficient quality to determine whether it has properties affecting fatigue or any other condition. The U.S. Food and Drug Administration (FDA) has issued warning letters to manufacturers of R. rosea dietary supplement products unapproved as new drugs, adulterated, misbranded and in federal violation for not having proof of safety or efficacy for the advertised conditions of alleviating Raynaud syndrome, altitude sickness, depression or cancer. A 2012 report by the European Medicines Agency on literature concerning the dried extract of R. rosea stated that "The published clinical trials exhibit considerable deficiencies in their quality. Therefore 'well-established use' cannot be accepted".

Sources: en.wikipedia.org

Further detail

=== Constitutional reform === In 1988, new amendments to the Yugoslav Constitution were adopted, initiating a process of democratization. During 1988 and 1989, a successful round of coups in the Communist party leadership, known as the anti-bureaucratic revolution, in Vojvodina, Kosovo as well as Montenegro, replaced autonomous leaderships in this regions. The coups were led by Slobodan Milošević; supporter of Serbian nationalism. The events were condemned by the communist governments of the western Yugoslav republics (especially SR Slovenia and SR Croatia), who successfully resisted the attempts to expand the revolt onto their territories, and turned against Milošević. The rising antagonism eventually resulted in the dissolution of the ruling League of Communists of Yugoslavia in 1990, and subsequently in the breakup of Yugoslavia. In 1989, Slobodan Milošević was elected as President of the State Presidency of Serbia. He demanded that the federal Yugoslav government act for the interests of Serbia in Kosovo by sending in the Yugoslav People's Army to suppress separatism in the province. At the same time, several reforms of federal electoral system were proposed, with Serbia supporting a "one-citizen, one-vote" system, which would have given a majority of votes to Serbs. By that time, ethnic tensions in Yugoslavia increased, and the ruling League of Communists of Yugoslavia collapsed, followed by the crisis of federal institutions.

=== Acidity === Thiols are easily deprotonated. Relative to the alcohols, thiols are more acidic. The conjugate base of a thiol is called a thiolate. Butanethiol has a pKa of 10.5 vs 15 for butanol. Thiophenol has a pKa of 6, versus 10 for phenol. A highly acidic thiol is pentafluorothiophenol (C6F5SH) with a pKa of 2.68. Thus, thiolates can be obtained from thiols by treatment with alkali metal hydroxides.

The combination of these two steps, both of which are catalyzed by aminoacyl tRNA synthetase, produces a charged tRNA that is ready to add amino acids to the growing polypeptide chain. In addition to binding an amino acid, tRNA has a three nucleotide unit called an anticodon that base pairs with specific nucleotide triplets on the mRNA called codons; codons encode a specific amino acid. This interaction is possible thanks to the ribosome, which serves as the site for protein synthesis. The ribosome possesses three tRNA binding sites: the aminoacyl site (A site), the peptidyl site (P site), and the exit site (E site). There are numerous codons within an mRNA transcript, and it is very common for an amino acid to be specified by more than one codon; this phenomenon is called degeneracy. In all, there are 64 codons, 61 of each code for one of the 20 amino acids, while the remaining codons specify chain termination.

Sources: en.wikipedia.org

Frequently asked questions

What did animal studies show?

Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.

Has cardarine been tested in humans?

Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.

Does cardarine improve athletic performance in people?

Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.

Is cardarine a SARM?

No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.

Network